Baba, M., Takashima, K., Miyake, H., Kanzaki, N., Teshima, K., Wang, X., . . . Iizawa, Y. (2005). TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans. American Society for Microbiology.
Citación estilo ChicagoBaba, Masanori, Katsunori Takashima, Hiroshi Miyake, Naoyuki Kanzaki, Koichiro Teshima, Xin Wang, Mitsuru Shiraishi, and Yuji Iizawa. TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans. American Society for Microbiology, 2005.
Cita MLABaba, Masanori, et al. TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans. American Society for Microbiology, 2005.